tirzepatide dose escalation for weight loss the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Why Increase Zepbound Dose? Doctor

The pharmacokinetic principle of half-life provides a framework for understanding drug elimination

found obese patients with no prior CUD diagnosis who received semaglutide had a 44% lower risk for a CUD diagnosis during the study period than those not receiving semaglutide (HR: 0.56)

Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome

For broader context on longevity-focused peptide approaches , our dedicated guide covers the landscape

Removing coverage of the drug will result in an estimated client savings of 10% to 15% year over year in the anti-obesity medication space for its clients who choose to cover these medications for weight loss, according to Blando

Oxidative stress leading to an altered redox status of mucosal glutathione is a major etiological factor in ulcerative colitis, an inflammatory bowel disease (IBD) [98]